The revenue stands at ₹8,276.89 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.73 per cent from ₹7,474.66 crore. This corresponds to a year-on-year *(YoY) growth of 32.04 per cent.
Operating Profit stands at ₹2,449.53 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.05 per cent from ₹2,354.24 crore. This corresponds to a year-on-year *(YoY) growth of 41.82 per cent.
PBDT stands at ₹2,470.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.02 per cent from ₹2,374.79 crore. This corresponds to a year-on-year *(YoY) growth of 44.08 per cent.
Profit Before Tax stands at ₹2,017.36 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.63 per cent from ₹1,928.00 crore. This corresponds to a year-on-year *(YoY) growth of 42.52 per cent.
Net Profit stands at ₹1,416.98 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.52 per cent from ₹1,468.67 crore. This represents a 16.01 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | 0.23% | 0.68% | -6.35% | -19.77% | -15.71% | 1.05% |
| Dr Reddy's Labs | 0.55% | -0.79% | 4.16% | 0.82% | -1.19% | -2.81% |
| Mankind Pharma | 1.06% | -1.84% | 2.61% | -5.48% | 10.91% | -4.98% |
| Aurobindo Pharma | 0.91% | -1.63% | -0.53% | 9.19% | 20.88% | 52.07% |
| Glenmark Pharma. | 0.26% | -1.39% | -6.80% | 0.64% | 0.11% | 20.90% |
| Alkem Lab | -1.71% | -1.91% | -4.03% | -7.71% | -8.21% | -8.19% |
| Biocon | 0.07% | 1.81% | -7.50% | -19.57% | -1.87% | -1.28% |
Chairperson : M D Gupta
Executive Director & CEO : Vinita Gupta
ED / MD / Promoter : Nilesh Gupta
ED / Global CFO / CRO / Head : Ramesh Swaminathan
Independent Non Exe. Director : K B S Anand
Independent Non Exe. Director : Mark D McDade
Independent Non Exe. Director : Jeffrey Kindler
Independent Non Exe. Director : Alfonso Zulueta
Independent Non Exe. Director : Punita Lal
Independent Director : Anand Kripalu
Company Sec. & Compli. Officer : Amit Kumar Gupta.